• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用上皮表面标志物上皮膜抗原增强膀胱癌检测:初步报告

Enhanced detection of bladder cancer using the epithelial surface marker epithelial membrane antigen: a preliminary report.

作者信息

Ring K S, Karp F, Benson M C

机构信息

Department of Urology, Columbia University, College of Physicians and Surgeons, New York, NY 10032.

出版信息

J Occup Med. 1990 Sep;32(9):904-9. doi: 10.1097/00043764-199009000-00030.

DOI:10.1097/00043764-199009000-00030
PMID:2074517
Abstract

The flow cytometry (FCM) technique allows for the rapid quantitative analysis of the DNA content of individual cells. In a variety of genitourinary tumors, DNA ploidy has a significant impact upon prognosis and ultimate patient survival. In patients having transitional cell cancer (TCC) of the bladder, FCM of voided urine and bladder barbotage specimens is highly correlated with cytologic analysis in the detection of malignant cells. One problem with this technique has been decreased sensitivity in samples containing large numbers of inflammatory cells. To improve FCM detection of TCC in bladder wash specimens, we developed a technique using a monoclonal antibody (Mab) specific to human, epithelial membrane antigen (EMA). The EMA cell-surface marker enabled us to differentiate bladder epithelial cells from lymphocytes and cellular debris. In combination with DNA analysis using propidium iodide, the EMA Mab increased the sensitivity and specificity of FCM compared to conventional analysis using propidium iodide alone. We conclude that epithelial cell-surface antigen staining using both EMA Mab and DNA staining can increase the FCM detection of TCC in bladder wash specimens.

摘要

流式细胞术(FCM)技术可对单个细胞的DNA含量进行快速定量分析。在多种泌尿生殖系统肿瘤中,DNA倍性对预后及患者最终生存有着重大影响。在患有膀胱移行细胞癌(TCC)的患者中,对排尿及膀胱灌洗标本进行FCM检测,在检测恶性细胞方面与细胞学分析高度相关。该技术的一个问题是在含有大量炎性细胞的样本中敏感性降低。为提高膀胱冲洗标本中TCC的FCM检测率,我们开发了一种使用针对人上皮膜抗原(EMA)的单克隆抗体(Mab)的技术。EMA细胞表面标志物使我们能够将膀胱上皮细胞与淋巴细胞及细胞碎片区分开来。与使用碘化丙啶进行DNA分析相结合,与单独使用碘化丙啶的传统分析相比,EMA Mab提高了FCM的敏感性和特异性。我们得出结论,使用EMA Mab进行上皮细胞表面抗原染色及DNA染色可提高膀胱冲洗标本中TCC的FCM检测率。

相似文献

1
Enhanced detection of bladder cancer using the epithelial surface marker epithelial membrane antigen: a preliminary report.利用上皮表面标志物上皮膜抗原增强膀胱癌检测:初步报告
J Occup Med. 1990 Sep;32(9):904-9. doi: 10.1097/00043764-199009000-00030.
2
Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.评估DD23作为膀胱癌病史患者复发性膀胱移行细胞癌检测标志物的价值。
Urology. 2003 Mar;61(3):539-43. doi: 10.1016/s0090-4295(02)02400-7.
3
Immunocytochemically demonstrated expression of epithelial membrane antigen and carcinoembryonic antigen by exfoliated urinary cells in patients with bladder cancer.
Urol Int. 1994;52(3):140-4. doi: 10.1159/000282593.
4
Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens.前列腺干细胞抗原的免疫细胞化学分析作为检测排尿标本中尿路上皮移行细胞癌的辅助标志物。
J Urol. 2003 Jun;169(6):2094-100. doi: 10.1097/01.ju.0000064929.43602.17.
5
[Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].[非侵入性尿液检测在膀胱癌诊断及预后标志物中的应用。BTAstat和NMP 22检测与使用抗Lewis X和486p3/12单克隆抗体的免疫细胞学检测的比较]
Urologe A. 2003 Apr;42(4):523-30. doi: 10.1007/s00120-002-0247-6. Epub 2003 Jan 17.
6
Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells.利用脱落膀胱细胞中肿瘤标志物的定量荧光图像分析进行膀胱癌风险评估。
Cancer. 1993 Oct 15;72(8):2461-9. doi: 10.1002/1097-0142(19931015)72:8<2461::aid-cncr2820720826>3.0.co;2-c.
7
Diagnostic performance of the urinary bladder carcinoma antigen ELISA test and multiparametric DNA/cytokeratin flow cytometry in urine voided samples from patients with bladder carcinoma.膀胱癌抗原酶联免疫吸附测定(ELISA)试验及多参数DNA/细胞角蛋白流式细胞术对膀胱癌患者晨尿样本的诊断性能
Cancer. 2001 Dec 1;92(11):2811-9. doi: 10.1002/1097-0142(20011201)92:11<2811::aid-cncr10101>3.0.co;2-t.
8
Detection of bladder tumors by immunostaining of the Lewis X antigen in cells from voided urine.通过对排尿细胞中Lewis X抗原进行免疫染色检测膀胱肿瘤。
Urology. 1995 Aug;46(2):173-7. doi: 10.1016/s0090-4295(99)80189-7.
9
Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.核基质蛋白、纤连蛋白、膀胱癌抗原及晨尿细胞学检查在膀胱肿瘤检测中的比较评估
J Urol. 2002 Aug;168(2):465-9.
10
DD23 Biomarker: a prospective clinical assessment in routine urinary cytology specimens from patients being monitored for TCC.DD23生物标志物:对接受TCC监测患者的常规尿液细胞学标本进行的前瞻性临床评估。
Urol Oncol. 2002 Sep-Oct;7(5):185-90. doi: 10.1016/s1078-1439(02)00188-6.

引用本文的文献

1
Expression of E-cadherin, β-catenin, and epithelial membrane antigen does not predict survival in patients with high-risk non-muscle-invasive bladder cancer.E-钙黏蛋白、β-连环蛋白和上皮膜抗原的表达不能预测高危非肌肉浸润性膀胱癌患者的生存率。
Cent Eur J Immunol. 2018;43(4):421-427. doi: 10.5114/ceji.2018.79509. Epub 2018 Dec 31.